Bio-Rad Labs: Things are changing | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Bio-Rad Labs: Things are changing

An SI Board Since January 2000

Posts	SubjectMarks	Bans
18	3	0

Emcee: Dave Chanoux	Type: Unmoderated

Introduction Compact

BioRad Laboratories' recent acquisition of Pasteur Sanofi Diagnostics will increase its Laboratory Diagnostic revenue substantially and has the potential for significant increases in earnings per share as well.

Here's why: 1. The acquisition was financed with debt, leveraging the company with limited dilution of equity; 2. the combined entity has potential to achieve economies of scale for operating efficiencies; 3. independent customer sets may allow the company to attain higher volumes through cross-selling; 4. expected increases in government spending in biological and health sciences in the US, Europe and Asia should boost business volume; 5. front end costs may negatively impact eps in the short term in favor of longer term earnings growth.

Things are certainly changing at BioRad. Where will these shares trade a year from now?

Dave Chanoux

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
18	Dave, Hear that Bio-Rad will be making the bio-assays for Luminex. Know anythin	Hamilton Rogers	-	5/1/2000
17	I'll make one more post about first quarter earnings to keep this thing ali	Dave Chanoux	-	4/30/2000
16	Dave, Sent copy of your e-mail to webmaster at Luminex and suggested that they	Hamilton Rogers	-	3/27/2000
15	Thanks for the link luminexcorp.com However, when I went there, all I got was	Dave Chanoux	-	3/26/2000
14	You may be interested in some of the new technology which Bio-Rad is now using.	Hamilton Rogers	-	3/24/2000
13	Back to distributing the news. Here is an interesting item covering intellectu	Dave Chanoux	-	3/5/2000
12	Thanks so much for the comments. It sure is nice to know that someone else has	Dave Chanoux	-	2/28/2000
11	I thought you could use some company here. I'm already a biorad owner, bu	jsabelko	-	2/25/2000
10	Time for our week-end words from the wise; this week in the form of a multiple	Dave Chanoux	-	2/25/2000
9	The facts emerge like a le Carre spy novel. Earlier this week Bio-Rad reported	Dave Chanoux	-	2/20/2000
8	Dave, For pain - take an aspirin. Put the Shakespeare back in your pocket. I	Dave Chanoux	-	2/13/2000
7	Fourth Quarter and Full Year results released today. "Pain oh piercing pa	Dave Chanoux	-	2/10/2000
6	A significant piece of business? Bio-Rad has been selected to provide a clinic	Dave Chanoux	-	2/6/2000
5	From the "will wonders never cease" department: "Bio-Rad Labs&q	Dave Chanoux	-	2/4/2000
4	Bio-Rad in the news today: Reuters reported that Moody's Investors Service	Dave Chanoux	-	2/3/2000
3	Time to get into quantitative data: Here is a brief history of Bio-Rad quarter	Dave Chanoux	-	1/29/2000
2	Here are some links which describe the Laboratory Diagnostics Business: Innova	Dave Chanoux	-	1/25/2000
1	But what about the cost of servicing that debt? And the likelihood of interest	Dave Chanoux	-	1/23/2000

Go to reply# or date (mm/dd/yy):